[Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis]

Takashi Itoh1, Miwa Uzuki, Tadashi Shimamura

  • 1Department of 1st Pathology, Department of Orthopedic Surgery, School of Medicine, Iwate Medical University, Morioka-city.

Ryumachi. [Rheumatism]
|April 3, 2002
PubMed
Abstract

Insights

Matrix metalloproteinases (MMPs) are key in rheumatoid arthritis (RA) joint destruction. This study found elevated MMP-13 activity in RA patients, highlighting its role in disease pathogenesis.

Area of Science:

  • Biochemistry
  • Immunology
  • Rheumatology

Context:

  • Rheumatoid arthritis (RA) is characterized by joint destruction.
  • Matrix metalloproteinases (MMPs) are implicated in RA pathogenesis.
  • MMP-13 is a newly defined enzyme with a significant role in joint destruction.

Purpose:

  • To measure the concentration and activity of MMP-1, MMP-9, and MMP-13 in serum and synovial fluid of RA patients.
  • To compare the dynamics of MMP-1, MMP-9, and MMP-13 in RA patients.
  • To investigate the expression of MMP-13 in synovial tissues of RA patients.

Summary:

  • Concentrations and activity levels of MMP-1, MMP-9, and MMP-13 were significantly higher in RA serum and synovial fluid compared to osteoarthritis (OA).
  • The activity ratio of MMP-13 was notably elevated in RA serum and synovial fluid.
  • MMP-13 positive cells were identified in synovial and pannus tissues, including synovial lining cells, endothelial cells, fibroblasts, monocytes, osteoblasts, and chondrocytes.

Impact:

  • This study elucidates the dynamics of MMPs, particularly MMP-13, in rheumatoid arthritis.
  • Findings suggest MMP-13 plays a crucial role in RA joint destruction.
  • Elevated MMP-13 activity in RA patients offers potential therapeutic targets.